Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lloyd F. Mayer
Comparison of Scheduled and Episodic Treatment Strategies of Infliximab in Crohn’s Disease
Gastroenterology
Hepatology
Gastroenterology
Related publications
Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Exclusive Enteral Nutrition Versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Individualized Treatment With Infliximab Therapy in Children With Crohn’s Disease Support Shorter Time Intervals Between Infusions
Journal of Drug Assessment
Infliximab Treatment Time and the Mucosal Healing Effect in Pediatric Patients With Severe Crohn’s Disease – Own Experience
Przeglad Gastroenterologiczny
Gastroenterology
Treatment Perspectives in Crohn’s Disease
Digestion
Gastroenterology
Prm142 - Quantitative Benefit-Risk Modelling of Biosimilars: A Case Study of Infliximab in Crohn’s Disease.
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dietary Treatment of Active Crohn’s Disease
Nursing standard (Royal College of Nursing (Great Britain) : 1987)
Medicine
Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Digestive Diseases and Sciences
Physiology
Gastroenterology